Next Article in Journal
Non-Retroviral Fossils in Vertebrate Genomes
Next Article in Special Issue
Activation of LTRs from Different Human Endogenous Retrovirus (HERV) Families by the HTLV-1 Tax Protein and T-Cell Activators
Previous Article in Journal
Next-Generation Dengue Vaccines: Novel Strategies Currently Under Development
Previous Article in Special Issue
Human T-Lymphotropic Virus Type 1 (HTLV-1) and Regulatory T Cells in HTLV-1-Associated Neuroinflammatory Disease
Article Menu

Article Versions

Export Article

Open AccessArticle
Viruses 2011, 3(10), 1815-1835; doi:10.3390/v3101815

Inhibition of Geranylgeranyl Transferase-I Decreases Cell Viability of HTLV-1-Transformed Cells

1
Virus Tumor Biology Section, Laboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
2
Vaccine Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
Deceased.
*
Author to whom correspondence should be addressed.
Received: 13 September 2011 / Accepted: 26 September 2011 / Published: 10 October 2011
(This article belongs to the Special Issue Recent Developments in HTLV Research)
Download PDF [1431 KB, uploaded 12 May 2015]

Abstract

Human T-cell leukemia virus type-1 (HTLV-1) is the etiological agent of adult T-cell leukemia (ATL), an aggressive and highly chemoresistant malignancy. Rho family GTPases regulate multiple signaling pathways in tumorigenesis: cytoskeletal organization, transcription, cell cycle progression, and cell proliferation. Geranylgeranylation of Rho family GTPases is essential for cell membrane localization and activation of these proteins. It is currently unknown whether HTLV-1-transformed cells are preferentially sensitive to geranylgeranylation inhibitors, such as GGTI-298. In this report, we demonstrate that GGTI-298 decreased cell viability and induced G2/M phase accumulation of HTLV-1-transformed cells, independent of p53 reactivation. HTLV-1-LTR transcriptional activity was inhibited and Tax protein levels decreased following treatment with GGTI-298. Furthermore, GGTI-298 decreased activation of NF-κB, a downstream target of Rho family GTPases. These studies suggest that protein geranylgeranylation contributes to dysregulation of cell survival pathways in HTLV-1-transformed cells.
Keywords: human T-cell leukemia virus type-1; HTLV-1; Tax; long terminal repeat; LTR; geranylgeranyltransferase; GGTI-298; small GTPase; NF-κB; p53; cell cycle human T-cell leukemia virus type-1; HTLV-1; Tax; long terminal repeat; LTR; geranylgeranyltransferase; GGTI-298; small GTPase; NF-κB; p53; cell cycle
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Edwards, D.C.; McKinnon, K.M.; Fenizia, C.; Jung, K.-J.; Brady, J.N.; Pise-Masison, C.A. Inhibition of Geranylgeranyl Transferase-I Decreases Cell Viability of HTLV-1-Transformed Cells. Viruses 2011, 3, 1815-1835.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top